The purpose of the programme is to reduce the incidence and severity of shingles disease in adults aged 70 to 79.
Offering the shingles vaccine routinely to individuals at the age of 70 aims to boost immunity to prevent the development of shingles in later years, while significantly reducing the incidence of post-herpetic neuralgia.
Eligibility
(who have not previously had a shingles vaccination)
The vaccine will be routinely offered to adults aged 70 on 1st September 2014 (born 02/09/1943 to 01/09/1944)
In conjunction with this, a catch-up programme will be available for adults aged 78 or 79 on 1st September 2014.
